Pharmacokinetics of meropenem in preterm neonates

Therapeutic Drug Monitoring

Volumn 23, Issue 3, 2001, Pages 198-201

  Van Enk, J Gert ^a   Touw, Daniel J ^a,b   Lafeber, Harry N ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Apotheek Haagse Ziekenhuizen   (Netherlands)

Author keywords

Meropenem; Neonate; Pharmacokinetics

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM; MEROPENEM;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; COMPARTMENT MODEL; DOSE TIME EFFECT RELATION; DRUG HALF LIFE; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NEWBORN; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; PREMATURITY; PRIORITY JOURNAL; SIDE EFFECT;

HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; THIENAMYCINS;

EID: 0035021125     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200106000-00003     Document Type: Article

References (8)

1. Bradley JS, Faulkner KL, Klugman KP. Efficacy, safety and tolerability of meropenem as empiric antibiotic therapy in hospitalized pediatric patients. Pediatr Infect Dis J 1996;15:749-57.
2. Martinkova J, de Groot R, Chladek J, et al. Meropenem pharmacokinetics in pre-term and full-term neonates. 7th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, March 26-30, 1995 (abstract 686).
3. Jones HK, Kelly HC, Hutchison M, et al. A comparison of the pharmacokinetics of meropenem after intravenous administration by injection over 2, 3 and 5 minutes. Eur J Drug Metab Pharmacokinet 1997;22:193-9.
4. Blumer JL. Pharmacokinetic determinants of carbapenem therapy in neonates and children. Pediatr Infect Dis J 1996;15:733-7.
5. Van den Anker JN. Pharmacokinetics and renal function in preterm infants. Acta Paediatr 1996;85:1393-9.
6. Proost JH, Meijer DKF. MW£harm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring. Comput Biol Med 1992;22:155-63.
7. Mouton JW, Touw DJ, Horrevorts AM, Vinks AATMM. Comparative pharmacokinetics of the carbapenems: clinical implications. Clin Pharmacokinet 2000;39:185-201.
8. Pfaller MA, Jones RN. A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated worldwide. Diagn Microbiol Infect Dis 1997;28:157-63.